First Time Loading...

Enlivex Therapeutics Ltd
NASDAQ:ENLV

Watchlist Manager
Enlivex Therapeutics Ltd Logo
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Watchlist
Price: 1.62 USD Market Closed
Updated: May 5, 2024

Enlivex Therapeutics Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Enlivex Therapeutics Ltd
Revenue Peer Comparison

Comparables:
CLGN
KMDA
URGN
ENTX
B
BONS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Revenue
$11m
CAGR 3-Years
21%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Revenue
$142.5m
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Urogen Pharma Ltd
NASDAQ:URGN
Revenue
$82.7m
CAGR 3-Years
91%
CAGR 5-Years
136%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Revenue
₪0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Enlivex Therapeutics Ltd's Revenue?
Revenue
0 USD

Based on the financial report for Dec 31, 2023, Enlivex Therapeutics Ltd's Revenue amounts to 0 USD.